-

Letter to ViewRay Lenders/Investment Bankers and Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies

WASHINGTON--(BUSINESS WIRE)--Since the announcement regarding the closing of ViewRay on October 25, 2023, competitors have raced to decommission the ViewRay Systems, replacing them with their own products by establishing relationships with companies that service/decommission/sell refurbished or used equipment—making time of the essence to preserve this valuable technology.

While competitors may be motivated to remove ViewRay's systems and offer alternatives, there’s a real possibility that the entire community of Radiation Therapy Professionals and Hospital/Cancer Center Administrations may become disillusioned about MR Linac —its high cost of purchase, installation, commissioning, etc.—possibly deterring companies from trying to sell MR Linac Technologies in the future.

TeamBest Global (TBG) is a lean enterprise consisting of multiple companies, some of which were failing when Krishnan Suthanthiran acquired them. TBG companies have grown to support 450+ employees globally and work to revitalize struggling companies with new product lines.

Suthanthiran considers his staff his family, striving daily to ensure that employees—along with suppliers and contractors—are paid and customers are happy and satisfied. Years ago in Moscow, Russia, when asked by a Radiation Oncology Chairwoman what excites him as he approaches each day, Suthanthiran shared that his goal is to be a "cheerleader" and to help save lives every day, regardless of where he is.

Some of Suthanthiran's staff have worked 40+ years in TBG companies. TBG’s motto is stability, consistency, and excellence every day.

Suthanthiran has personally invested 100 million+ USD in establishing Best Particle Therapy and Best Cyclotron Systems. His companies offer a wide range of cyclotrons and synchrotrons for radioisotope production, research, and therapy. They are proud to be one of the most sophisticated cyclotron companies in the world.

Best Medical International (BMI), a TBG company, stopped producing Iridium 192 Seeds in Nylon Ribbons and Gold 198 Seeds this year, having received no new orders for over a year. BMI, however, decided to maintain the capabilities to produce the product in the future.

Suthanthiran hopes that ViewRay's lenders and customers appreciate the value of its technology and decide to keep it in the hands of a USA-based company for future innovations and upgrades.

For more information, visit www.teambest.com, Letter to ViewRay Customers, Open Letter to ViewRay Customers, Letter to Lenders/Investment Bankers & ViewRay Customers, or read about our new initiatives.

Contacts

Krishnan Suthanthiran, 703-451-2378, krish@teambest.com

TeamBest Global Companies


Release Versions

Contacts

Krishnan Suthanthiran, 703-451-2378, krish@teambest.com

More News From TeamBest Global Companies

To Leaders of Canadian First Nations and Federal/Provincial Governments—Fueling the Future with Kitsault Energy

WASHINGTON--(BUSINESS WIRE)--In 2013, Dr. Suthanthiran, President/Founder of TeamBest Global Companies, announced his dedicated energy pipeline corridor/export port/terminal to carry all of Canada’s energy products to Kitsault, BC, Canada, a town owned by Suthanthiran, northwest of Prince Rupert, BC. Suthanthiran, a healthcare professional, has devoted over fifty years to cheering, helping, and saving lives daily. The dedicated pipeline corridor is now a reality, w/multiple pipelines approved a...

Best Vascular/Novoste Celebrates 24th Anniversary of Vascular Brachytherapy Approval & Use of by US FDA

WASHINGTON--(BUSINESS WIRE)--It’s been over 30 years since the first vascular brachytherapy (VBT) animal experiments and human clinical trials were performed and 24 years since the approval of VBT for human clinical use for the treatment of in-stent coronary artery restenosis by the US FDA on November 3, 2000. Dr. Paul Teirstein, at Scripps Clinic in La Jolla, California, in collaboration with Virginia-based Best Medical International (BMI), began the first randomized, double-blind human clinic...

BCF, BREF and TBG Companies Seek Global Financial Support to Establish 1000s of Best Cure Pro Health and Medical Centers

WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran is the Founder and President of the Best Cure Foundation (BCF), a non-profit 501(c)(3) corporation established in Springfield, Virginia, USA, in 2007. He also established the Brachytherapy Research & Education Foundation (BREF) as a non-profit in Springfield, Virginia, USA, in 1987. Additionally, Suthanthiran founded TeamBest Global (TBG) Companies in 1977 and has acquired several companies over the last 20 years. Suthanthiran's journey...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.